160 related articles for article (PubMed ID: 20876702)
1. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.
Bai X; Zhu Y; Jin Y; Guo X; Qian G; Chen T; Zhang J; Wang J; Groopman JD; Gu J; Tu H
Carcinogenesis; 2011 Jan; 32(1):63-8. PubMed ID: 20876702
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
3. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
[TBL] [Abstract][Full Text] [Related]
4. Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China.
Qu LS; Zhu J; Liu TT; Shen XZ; Chen TY; Ni ZP; Ni RZ; Lu CH
Hepatol Res; 2014 Nov; 44(12):1186-95. PubMed ID: 24341484
[TBL] [Abstract][Full Text] [Related]
5. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
Tanaka Y; Mukaide M; Orito E; Yuen MF; Ito K; Kurbanov F; Sugauchi F; Asahina Y; Izumi N; Kato M; Lai CL; Ueda R; Mizokami M
J Hepatol; 2006 Nov; 45(5):646-53. PubMed ID: 16935384
[TBL] [Abstract][Full Text] [Related]
6. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
7. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
8. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
Shinkai N; Tanaka Y; Ito K; Mukaide M; Hasegawa I; Asahina Y; Izumi N; Yatsuhashi H; Orito E; Joh T; Mizokami M
J Clin Microbiol; 2007 Oct; 45(10):3191-7. PubMed ID: 17652471
[TBL] [Abstract][Full Text] [Related]
9. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
[TBL] [Abstract][Full Text] [Related]
10. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
[TBL] [Abstract][Full Text] [Related]
12. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
[TBL] [Abstract][Full Text] [Related]
13. Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.
Qu L; Kuai X; Liu T; Chen T; Ni Z; Shen X
PLoS One; 2013; 8(3):e59583. PubMed ID: 23555717
[TBL] [Abstract][Full Text] [Related]
14. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.
Lyu H; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ
J Viral Hepat; 2013 Mar; 20(3):219-24. PubMed ID: 23383661
[TBL] [Abstract][Full Text] [Related]
17. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
19. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
[TBL] [Abstract][Full Text] [Related]
20. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
